Laquinimod efficacy in relapsing-remitting multiple sclerosis: how to understand why and if studies disagree.

MLA

Cutter, Gary R., et al. “Laquinimod Efficacy in Relapsing-Remitting Multiple Sclerosis: How to Understand Why and If Studies Disagree.” BMC Neurology, vol. 16, Sept. 2016, pp. 1–7. EBSCOhost, https://doi.org/10.1186/s12883-016-0702-4.

APA

Cutter, G. R., Knappertz, V., Sasson, N., & Ladkani, D. (2016). Laquinimod efficacy in relapsing-remitting multiple sclerosis: how to understand why and if studies disagree. BMC Neurology, 16, 1–7. https://doi.org/10.1186/s12883-016-0702-4

Chicago

Cutter, Gary R., Volker Knappertz, Nissim Sasson, and David Ladkani. 2016. “Laquinimod Efficacy in Relapsing-Remitting Multiple Sclerosis: How to Understand Why and If Studies Disagree.” BMC Neurology 16 (September): 1–7. doi:10.1186/s12883-016-0702-4.